CIK 0001644963 · Non-accelerated filer<br>Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474113275
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-02 | Herskowitz Neil Director | Sale | −23 | $2.00 | $46 | 97 |
| 2024-11-05 | KRANZLER JAY D Director | Sale | −61 | $2.24 | $137 | 559 |
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −264,000 | $0.14 | $37K | 681,000 |
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −18,000 | $0.15 | $3K | 22,000 |
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −61,000 | $0.14 | $9K | 74,000 |
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −126,000 | $0.14 | $18K | 215,800 |
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −128,000 | $0.14 | $18K | 147,000 |
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −20,000 | $0.14 | $3K | 80,000 |
| 2022-10-11 | InvaGen Pharmaceuticals, Inc. 10% owner | Sale | −388,888 | $7.71 | $3.0M | 0 |
| 2021-09-15 | Vazzano Joseph Walter Chief Financial Officer | Sale | −7,160 | $1.62 | $12K | 65,252 |
| 2020-08-20 | Vazzano Joseph Walter Chief Financial Officer | Sale | −3,840 | $12.13 | $47K | 57,412 |
| 2019-08-09 | Vazzano Joseph Walter Chief Financial Officer | Sale | −2,375 | $5.56 | $13K | 56,663 |
| 2019-08-08 | Vazzano Joseph Walter Chief Financial Officer | Sale | −2,313 | $5.62 | $13K | 59,038 |
Page 1 of 1 · 13 trades